List of Tables
Table 1. Global Dermatology OTC Medications Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Dermatology OTC Medications Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Dermatology OTC Medications Market Competitive Situation by Manufacturers in 2025
Table 4. Global Dermatology OTC Medications Sales (M Units) of Key Manufacturers (2021–2026)
Table 5. Global Dermatology OTC Medications Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Dermatology OTC Medications Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Dermatology OTC Medications Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Dermatology OTC Medications Average Price (USD/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Dermatology OTC Medications, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Dermatology OTC Medications, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Dermatology OTC Medications, Product Types and Applications
Table 12. Global Key Manufacturers of Dermatology OTC Medications, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dermatology OTC Medications Companies by Tier (Tier 1, Tier 2, Tier 3), based on Dermatology OTC Medications Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Dermatology OTC Medications Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Dermatology OTC Medications Sales by Region (M Units), 2021–2026
Table 18. Global Dermatology OTC Medications Sales Market Share by Region (2021–2026)
Table 19. Global Dermatology OTC Medications Sales by Region (M Units), 2027–2032
Table 20. Global Dermatology OTC Medications Sales Market Share by Region (2027–2032)
Table 21. Global Dermatology OTC Medications Revenue by Region (US$ Million), 2021–2026
Table 22. Global Dermatology OTC Medications Revenue Market Share by Region (2021–2026)
Table 23. Global Dermatology OTC Medications Revenue by Region (US$ Million), 2027–2032
Table 24. Global Dermatology OTC Medications Revenue Market Share by Region (2027–2032)
Table 25. North America Dermatology OTC Medications Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Dermatology OTC Medications Sales by Country (M Units), 2021–2026
Table 27. North America Dermatology OTC Medications Sales by Country (M Units), 2027–2032
Table 28. North America Dermatology OTC Medications Revenue by Country (US$ Million), 2021–2026
Table 29. North America Dermatology OTC Medications Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Dermatology OTC Medications Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Dermatology OTC Medications Sales by Country (M Units), 2021–2026
Table 32. Europe Dermatology OTC Medications Sales by Country (M Units), 2027–2032
Table 33. Europe Dermatology OTC Medications Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Dermatology OTC Medications Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Dermatology OTC Medications Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Dermatology OTC Medications Sales by Region (M Units), 2021–2026
Table 37. Asia Pacific Dermatology OTC Medications Sales by Region (M Units), 2027–2032
Table 38. Asia Pacific Dermatology OTC Medications Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Dermatology OTC Medications Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Dermatology OTC Medications Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Dermatology OTC Medications Sales by Country (M Units), 2021–2026
Table 42. Latin America Dermatology OTC Medications Sales by Country (M Units), 2027–2032
Table 43. Latin America Dermatology OTC Medications Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Dermatology OTC Medications Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Dermatology OTC Medications Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Dermatology OTC Medications Sales by Country (M Units), 2021–2026
Table 47. Middle East and Africa Dermatology OTC Medications Sales by Country (M Units), 2027–2032
Table 48. Middle East and Africa Dermatology OTC Medications Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Dermatology OTC Medications Revenue by Country (US$ Million), 2027–2032
Table 50. Global Dermatology OTC Medications Sales (M Units) by Type (2021–2026)
Table 51. Global Dermatology OTC Medications Sales (M Units) by Type (2027–2032)
Table 52. Global Dermatology OTC Medications Sales Market Share by Type (2021–2026)
Table 53. Global Dermatology OTC Medications Sales Market Share by Type (2027–2032)
Table 54. Global Dermatology OTC Medications Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Dermatology OTC Medications Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Dermatology OTC Medications Revenue Market Share by Type (2021–2026)
Table 57. Global Dermatology OTC Medications Revenue Market Share by Type (2027–2032)
Table 58. Global Dermatology OTC Medications Price (USD/Unit) by Type (2021–2026)
Table 59. Global Dermatology OTC Medications Price (USD/Unit) by Type (2027–2032)
Table 60. Global Dermatology OTC Medications Sales (M Units) by Application (2021–2026)
Table 61. Global Dermatology OTC Medications Sales (M Units) by Application (2027–2032)
Table 62. Global Dermatology OTC Medications Sales Market Share by Application (2021–2026)
Table 63. Global Dermatology OTC Medications Sales Market Share by Application (2027–2032)
Table 64. Global Dermatology OTC Medications Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Dermatology OTC Medications Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Dermatology OTC Medications Revenue Market Share by Application (2021–2026)
Table 67. Global Dermatology OTC Medications Revenue Market Share by Application (2027–2032)
Table 68. Global Dermatology OTC Medications Price (USD/Unit) by Application (2021–2026)
Table 69. Global Dermatology OTC Medications Price (USD/Unit) by Application (2027–2032)
Table 70. Bayer Company Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 73. Bayer Dermatology OTC Medications Product
Table 74. Bayer Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 78. GSK Dermatology OTC Medications Product
Table 79. GSK Recent Developments/Updates
Table 80. Teva Company Information
Table 81. Teva Description and Business Overview
Table 82. Teva Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 83. Teva Dermatology OTC Medications Product
Table 84. Teva Recent Developments/Updates
Table 85. Johnson & Johnson Company Information
Table 86. Johnson & Johnson Description and Business Overview
Table 87. Johnson & Johnson Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 88. Johnson & Johnson Dermatology OTC Medications Product
Table 89. Johnson & Johnson Recent Developments/Updates
Table 90. Novartis Company Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 93. Novartis Dermatology OTC Medications Product
Table 94. Novartis Recent Developments/Updates
Table 95. Viatris Company Information
Table 96. Viatris Description and Business Overview
Table 97. Viatris Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 98. Viatris Dermatology OTC Medications Product
Table 99. Viatris Recent Developments/Updates
Table 100. Sun Pharmaceutical Company Information
Table 101. Sun Pharmaceutical Description and Business Overview
Table 102. Sun Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 103. Sun Pharmaceutical Dermatology OTC Medications Product
Table 104. Sun Pharmaceutical Recent Developments/Updates
Table 105. Aurobindo Company Information
Table 106. Aurobindo Description and Business Overview
Table 107. Aurobindo Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 108. Aurobindo Dermatology OTC Medications Product
Table 109. Aurobindo Recent Developments/Updates
Table 110. Galderma Company Information
Table 111. Galderma Description and Business Overview
Table 112. Galderma Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 113. Galderma Dermatology OTC Medications Product
Table 114. Galderma Recent Developments/Updates
Table 115. CR SANJIU Company Information
Table 116. CR SANJIU Description and Business Overview
Table 117. CR SANJIU Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 118. CR SANJIU Dermatology OTC Medications Product
Table 119. CR SANJIU Recent Developments/Updates
Table 120. Dr. Reddy's Company Information
Table 121. Dr. Reddy's Description and Business Overview
Table 122. Dr. Reddy's Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 123. Dr. Reddy's Dermatology OTC Medications Product
Table 124. Dr. Reddy's Recent Developments/Updates
Table 125. Lupin Company Information
Table 126. Lupin Description and Business Overview
Table 127. Lupin Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 128. Lupin Dermatology OTC Medications Product
Table 129. Lupin Recent Developments/Updates
Table 130. Bausch Health Company Information
Table 131. Bausch Health Description and Business Overview
Table 132. Bausch Health Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 133. Bausch Health Dermatology OTC Medications Product
Table 134. Bausch Health Recent Developments/Updates
Table 135. Cipla Company Information
Table 136. Cipla Description and Business Overview
Table 137. Cipla Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 138. Cipla Dermatology OTC Medications Product
Table 139. Cipla Recent Developments/Updates
Table 140. Qilu Pharmaceutical Company Information
Table 141. Qilu Pharmaceutical Description and Business Overview
Table 142. Qilu Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 143. Qilu Pharmaceutical Dermatology OTC Medications Product
Table 144. Qilu Pharmaceutical Recent Developments/Updates
Table 145. Almirall Company Information
Table 146. Almirall Description and Business Overview
Table 147. Almirall Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 148. Almirall Dermatology OTC Medications Product
Table 149. Almirall Recent Developments/Updates
Table 150. Lingrui Company Information
Table 151. Lingrui Description and Business Overview
Table 152. Lingrui Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 153. Lingrui Dermatology OTC Medications Product
Table 154. Lingrui Recent Developments/Updates
Table 155. Kaken Pharmaceutical Company Information
Table 156. Kaken Pharmaceutical Description and Business Overview
Table 157. Kaken Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 158. Kaken Pharmaceutical Dermatology OTC Medications Product
Table 159. Kaken Pharmaceutical Recent Developments/Updates
Table 160. Jingwei Pharma Company Information
Table 161. Jingwei Pharma Description and Business Overview
Table 162. Jingwei Pharma Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 163. Jingwei Pharma Dermatology OTC Medications Product
Table 164. Jingwei Pharma Recent Developments/Updates
Table 165. Zhiyuan Phamra Company Information
Table 166. Zhiyuan Phamra Description and Business Overview
Table 167. Zhiyuan Phamra Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 168. Zhiyuan Phamra Dermatology OTC Medications Product
Table 169. Zhiyuan Phamra Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Dermatology OTC Medications Distributors List
Table 173. Dermatology OTC Medications Customers List
Table 174. Dermatology OTC Medications Market Trends
Table 175. Dermatology OTC Medications Market Drivers
Table 176. Dermatology OTC Medications Market Challenges
Table 177. Dermatology OTC Medications Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Dermatology OTC Medications
Figure 2. Global Dermatology OTC Medications Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Dermatology OTC Medications Market Share by Type: 2025 & 2032
Figure 4. External Use Product Picture
Figure 5. Oral Product Picture
Figure 6. Global Dermatology OTC Medications Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Dermatology OTC Medications Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Drug Store
Figure 10. Other
Figure 11. Global Dermatology OTC Medications Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Dermatology OTC Medications Market Size (US$ Million), 2021–2032
Figure 13. Global Dermatology OTC Medications Sales (M Units), 2021–2032
Figure 14. Global Dermatology OTC Medications Average Price (USD/Unit), 2021–2032
Figure 15. Dermatology OTC Medications Report Years Considered
Figure 16. Dermatology OTC Medications Sales Share by Manufacturers in 2025
Figure 17. Global Dermatology OTC Medications Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Dermatology OTC Medications Players: Market Share by Revenue in Dermatology OTC Medications in 2025
Figure 19. Dermatology OTC Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Dermatology OTC Medications Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Dermatology OTC Medications Sales Market Share by Country (2021–2032)
Figure 22. North America Dermatology OTC Medications Revenue Market Share by Country (2021–2032)
Figure 23. U.S. Dermatology OTC Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Dermatology OTC Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Dermatology OTC Medications Sales Market Share by Country (2021–2032)
Figure 26. Europe Dermatology OTC Medications Revenue Market Share by Country (2021–2032)
Figure 27. Germany Dermatology OTC Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Dermatology OTC Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Dermatology OTC Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Dermatology OTC Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Dermatology OTC Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Dermatology OTC Medications Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Dermatology OTC Medications Revenue Market Share by Region (2021–2032)
Figure 34. China Dermatology OTC Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Dermatology OTC Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Dermatology OTC Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Dermatology OTC Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Dermatology OTC Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Taiwan Dermatology OTC Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Indonesia Dermatology OTC Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Thailand Dermatology OTC Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Malaysia Dermatology OTC Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Philippines Dermatology OTC Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Dermatology OTC Medications Sales Market Share by Country (2021–2032)
Figure 45. Latin America Dermatology OTC Medications Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Dermatology OTC Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Dermatology OTC Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Dermatology OTC Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Dermatology OTC Medications Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Dermatology OTC Medications Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Dermatology OTC Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Dermatology OTC Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Dermatology OTC Medications Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Dermatology OTC Medications by Type (2021–2032)
Figure 55. Global Revenue Market Share of Dermatology OTC Medications by Type (2021–2032)
Figure 56. Global Dermatology OTC Medications Price (USD/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Dermatology OTC Medications by Application (2021–2032)
Figure 58. Global Revenue Market Share of Dermatology OTC Medications by Application (2021–2032)
Figure 59. Global Dermatology OTC Medications Price (USD/Unit) by Application (2021–2032)
Figure 60. Dermatology OTC Medications Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
